EP4034248
COMPOSITE BIOMARKER FOR CANCER THERAPY
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
24.9.2020EP published:
20.5.2026EP application number:
20790106.7
EPO information:
European Patent Register
Max expiry date:
23.9.2040Expiry date:
23.9.2026
Title in English:
COMPOSITE BIOMARKER FOR CANCER THERAPYLanguage of the patent:
English
Timeline
Today
24.9.2020EP application
20.5.2026EP Publication
23.9.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
SANTUCCI PEREIRA DEL BUONO, JuliaAddress:
Princeton, New Jersey 08543, US
Name:
NELSON, David MartinAddress:
Princeton, New Jersey 08543, US
Name:
KANDOUSSI, Enzo YacobiAddress:
Princeton, New Jersey 08543, US
Name:
FISCHER, Bruce S.Address:
Princeton, New Jersey 08543, US
Name:
WIND-ROTOLO, Megan M.Address:
Princeton, New Jersey 08543, US
Name:
ISHII, YukoAddress:
Princeton, New Jersey 08543, US
Name:
GREENAWALT, Danielle MarieAddress:
Princeton, New Jersey 08543, US
Priority
Number:
201962905933 PDate:
25.9.2019Country:
US
Classification
Categories:
A61P 35/00, A61P 37/04, C12Q 1/68